These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9757910)

  • 21. New strategies for early diagnosis of heart allograft rejection.
    Tugulea S; Ciubotariu R; Colovai AI; Liu Z; Itescu S; Schulman LL; Fisher PE; Hardy MA; Rose EA; Michler RE; Cortesini R; Suciu-Foca N
    Transplantation; 1997 Sep; 64(6):842-7. PubMed ID: 9326408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self determinant selection and acquisition of the autoimmune T cell repertoire.
    Benichou G; Tam RC; Orr PI; Garovoy MR; Fedoseyeva EV
    Immunol Res; 1996; 15(3):234-45. PubMed ID: 8902578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of autoimmunity after allotransplantation.
    Benichou G; Alessandrini A; Charrad RS; Wilkes DS
    Front Biosci; 2007 May; 12():4362-9. PubMed ID: 17485380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways of Antigen Recognition by T Cells in Allograft Rejection.
    Carnel N; Lancia HH; Guinier C; Benichou G
    Transplantation; 2023 Apr; 107(4):827-837. PubMed ID: 36398330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV-B cells as antigen presenting cells in characterization of the self/donor context of allorecognition by T lymphocytes.
    Drouet C; Arvieux C; Devouassoux G; Csopaki F; Chavanon O; Brichon PY; Letoublon C; Zarski JP; Barnoud D; Pison C
    Transpl Immunol; 1998 Dec; 6(4):209-15. PubMed ID: 10342734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides.
    Oluwole SF; Chowdhury NC; Jin MX; Hardy MA
    Transplantation; 1993 Dec; 56(6):1523-7. PubMed ID: 8279028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA monomers as a tool to monitor indirect allorecognition.
    Breman E; van Miert PP; van der Steen DM; Heemskerk MH; Doxiadis II; Roelen D; Claas FH; van Kooten C
    Transplantation; 2014 Jun; 97(11):1119-27. PubMed ID: 24798312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
    Benichou G; Valujskikh A; Heeger PS
    J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology and the challenge of transplantation.
    Alonso Arias R; López-Vázquez A; López-Larrea C
    Adv Exp Med Biol; 2012; 741():27-43. PubMed ID: 22457101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen Presentation in Transplantation.
    Alegre ML; Lakkis FG; Morelli AE
    Trends Immunol; 2016 Dec; 37(12):831-843. PubMed ID: 27743777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
    Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
    Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The allogeneic response and tumor immunity.
    Fabre JW
    Nat Med; 2001 Jun; 7(6):649-52. PubMed ID: 11385492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of T cell responses to a self-antigen following allotransplantation.
    Fedoseyeva EV; Tam RC; Popov IA; Orr PL; Garovoy MR; Benichou G
    Transplantation; 1996 Mar; 61(5):679-83. PubMed ID: 8607166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structural basis of T-cell allorecognition.
    Whitelegg A; Barber LD
    Tissue Antigens; 2004 Feb; 63(2):101-8. PubMed ID: 14705981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of human alloantigen-specific T cells from peripheral blood.
    Jama BP; Morris GP
    J Vis Exp; 2014 Nov; (93):e52257. PubMed ID: 25490283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
    Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
    J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of alloreactive T cells is a consequence of the presentation of many peptides by allogeneic MHC molecules.
    Salom R; Brookes P; Hornick P; Lechler R
    Transplant Proc; 1995 Dec; 27(6):3579. PubMed ID: 8540111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.